一个模块化平台,用于增强向质母细胞瘤的药物输送,使用有针对性的多域蛋白组件.
Andrew L Wang1,2, Aparajita Bhattacharya1,2, Frances Lee1
1Department of Chemical and Biomolecular Engineering, New York University Tandon School of Engineering, 6 MetroTech Center, Brooklyn, NY, 11201, USA.
Angewandte Chemie (International ed. in English)
|July 3, 2025
概括
研究人员设计了蛋白质纳米载体,以改善水性药物输送,以治疗多种质母细胞瘤 (GBM). 增强的向多域蛋白组合 (TMPA) 显示药物负载和细胞吸收增加,表明GBM治疗的潜力.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 在瘤学瘤学.
背景情况:
- 基于蛋白质的纳米载体提供生物降解性和生物屏障透.
- 水性药物的向输送对于治疗多种质母细胞瘤 (GBM) 至关重要.
研究的目的:
- 设计蛋白质纳米载体,以改善GBM治疗中的疏水性药物输送.
- 通过模块化蛋白质工程来提高针对性多域蛋白组合 (TMPA) 的有效性.
主要方法:
- 代蛋白质工程来修改卷轴-卷轴和RGD片区.
- 评估水力动力学尺寸,药物负载能力 (多克索鲁比辛) 和细胞吸收 (U87 GBM 细胞).
- 在GBM携带的小鼠体内药理动力学分析和体外光成像.
主要成果:
- 目标区域的多重性增加 (m) 增强了TMPA的细胞大小和药物负载 (多克索鲁比封装的1.7倍增加).
- TMPA在U87人类GBM细胞吸收上显示出1.3倍的改善.
- 在体内研究表明,在携带GBM的小鼠中,NIR-TMPA的分布阶段半衰期延长和优选瘤局部化.
结论:
- 模块化蛋白质工程有效地改善了TMPA用于GBM治疗的特性.
- TMPA表现出增强的药物输送和瘤积累,突出其治疗潜力.
- 进一步开发TMPA衍生物可以推进有针对性的GBM治疗策略.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
2.5K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.8K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
